Home > Press > Arrowhead Announces Completion of $2.76 Million Private Placement
Abstract:
Arrowhead Research Corporation ARWR today announced that it has completed a second and final closing of its private offering with selected institutional and accredited investors bringing the proceeds of the offering to a total of $2.76 million. The second closing of the offering was significantly oversubscribed and added $900,000 to the previously announced $1.8 million in proceeds from the offering.
Arrowhead Announces Completion of $2.76 Million Private Placement
Pasadena, CA | Posted on August 7th, 2009
Under the terms of the offering, Arrowhead sold 9.2 million units at a purchase price of $0.30 per unit, with each unit consisting of one share of common stock and one warrant to purchase one additional share of common stock at an exercise price of $0.50 per share.
This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any state.
####
About Arrowhead Research Corporation
Arrowhead Research Corporation ARWR is a nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy. Arrowhead is seeking to build value for shareholders through the progress of majority owned subsidiaries. Currently, Arrowhead has four subsidiaries commercializing nanotech products and applications and minority investments in two privately held nanobiotech companies.
For more information, please click here
Contacts:
Investor Relations Contact:
The Piacente Group, Inc.
Brandi Floberg
212-481-2050
Copyright © Arrowhead Research Corporation
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
News and information
Nanoparticle Harnesses Powerful Radiation Therapy for Cancer May 20th, 2013
Microneedle-Delivered Nanoparticles Boost Antitumor Vaccines May 20th, 2013
Competition in the Quantum World May 20th, 2013
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Investments/IPO's/Splits
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013
Announcements
Competition in the Quantum World May 20th, 2013
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Penn engineers' nanoantennas improve infrared sensing May 20th, 2013
Researchers Perform Fastest Measurements Ever Made of Ion Channel Proteins May 20th, 2013